Growth Metrics

Pacific Biosciences Of California (PACB) Change in Acquisitions & Divestments (2016 - 2025)

Pacific Biosciences Of California (PACB) has 16 years of Change in Acquisitions & Divestments data on record, last reported at -$280.1 million in Q4 2025.

  • For Q4 2025, Change in Acquisitions & Divestments fell 346.71% year-over-year to -$280.1 million; the TTM value through Sep 2025 reached $393.6 million, down 36.38%, while the annual FY2024 figure was $594.0 million, 22.81% down from the prior year.
  • Change in Acquisitions & Divestments reached -$280.1 million in Q4 2025 per PACB's latest filing, down from $84.6 million in the prior quarter.
  • Across five years, Change in Acquisitions & Divestments topped out at $320.1 million in Q3 2023 and bottomed at -$280.1 million in Q4 2025.
  • Average Change in Acquisitions & Divestments over 5 years is $92.7 million, with a median of $122.1 million recorded in 2022.
  • Peak YoY movement for Change in Acquisitions & Divestments: soared 264.8% in 2021, then tumbled 346.71% in 2025.
  • A 5-year view of Change in Acquisitions & Divestments shows it stood at $178.2 million in 2021, then crashed by 168.5% to -$122.1 million in 2022, then surged by 213.28% to $138.3 million in 2023, then dropped by 17.89% to $113.5 million in 2024, then crashed by 346.71% to -$280.1 million in 2025.
  • Per Business Quant database, its latest 3 readings for Change in Acquisitions & Divestments were -$280.1 million in Q4 2025, $84.6 million in Q3 2025, and $82.0 million in Q2 2025.